Category: VascularSyndicate content

Vascular

DePuy's Codman Neuro expands in Asia Pacific with new approvals

September 8, 2014 by Arezu Sarvestani

Codman Neuro prepares to widen its Asia Pacific footprint with regulatory approvals in China, South Korea and Taiwan for its Revive SE thrombectomy system.

DePuy's Codman Neuro touts Asia Pacific approvals for thrombectomy device

Massachusetts-based Codman Neuro is preparing to take Asia Pacific by storm with new regulatory wins in China, South Korea and Taiwan for the company's Revive SE thrombectomy device.

Cook's recall gets FDA's highest-risk label

September 5, 2014 by Arezu Sarvestani

The FDA slaps its highest-risk Class I label on Cook Medical's recall of CloverSnare vascular retrieval snares.

Cook's recall gets FDA's highest-risk label

The FDA issued a warning this month on Cook Medical's medical device recall, warning that a defect in certain of the company's CloverSnare 4-Loop Vascular Retrieval Snares could harm patients.

Federal device regulators gave the recall Class I status, reserved for "situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Study: St. Jude's FFR helps boost stenting over drug therapy alone

September 2, 2014 by Arezu Sarvestani

Researchers report that St. Jude Medical's fractional flow reserve technology helps slash adverse events, especially urgent revascularizations, compared with medical therapy alone.

Study: St. Jude's FFR tech helps cut adverse events in half

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: J&J puts Cordis on the block

August 29, 2014 by Arezu Sarvestani

Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.

Report: J&J's selling its Cordis division

Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Sequent launches U.S. clinical trial of brain aneurysm device

August 29, 2014 by Arezu Sarvestani

California's Sequent Medical begins enrolling patients in an IDE clinical trial of its Web aneurysm embolization system.

Sequent launches U.S. clinical trial of brain aneurysm device

Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.

The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp